Definium Therapeutics, Inc. · NASDAQ:DFTX
Roberts Brandi received 62,500 Definium Therapeutics, Inc. shares as an award (Form 4)
Traded Aug 12, 2026 · Filed Aug 12, 2026
On Aug 12, 2026, Roberts Brandi (Chief Financial Officer) received 62,500 Definium Therapeutics, Inc. shares as an award, leaving 271,987 shares. Filed Aug 12, 2026 (Form 4).
- Awarded
- 62,500 shares
- Holding after
- 271,987 shares
- Trading plan
- No
- Role
- Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 12, 2026 | Common Shares | Award | 62,500 | 271,987 | Direct |
Source
Related
- Definium Therapeutics, Inc.
- Roberts Brandi
- Definium Therapeutics, Inc. shareholders
- Form 4 · Roberts Brandi · Sep 29, 2026
- Form 4 · Roberts Brandi · Sep 14, 2026
- Form 4 · Roberts Brandi · Jun 26, 2026
- Form 4 · Roberts Brandi · Jun 22, 2026
- Form 4 · Karlin Daniel · Sep 29, 2026
- Form 4 · Barrow Robert · Sep 29, 2026
- Form 4 · Wiley Matthew T. · Sep 29, 2026
- Form 4 · Sullivan Mark · Sep 29, 2026
- Form 4 · Krebs Andreas · Sep 18, 2026